Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: Six-year follow-up from the Stent or Surgery Trial (SoS)

Circulation

Volumn 118, Issue 4, 2008, Pages 381-388

  Booth, Jean ^a   Clayton, Tim ^b   Pepper, John ^a   Nugara, Fiona ^a   Flather, Marcus ^a,c   Sigwart, Ulrich ^d   Stables, Rodney H ^e  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Angioplasty; Coronary disease; Mortality; Stents; Surgery; Trials

Indexed keywords

ADULT; ANGINA PECTORIS; ANGIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVESSEL CORONARY ARTERY DISEASE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME; AGED; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE COURSE; MIDDLE AGED; MULTICENTER STUDY; STANDARD; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 49149123224     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.739144     Document Type: Article

References (30)

1. Hoffman SN, Tenbrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one to eight year outcomes. J Am Coll Cardiol. 2003;41: 1293-1304.
2. Bravata DM, Gienger AL, McDonald KM, Sundaram V, Perez-Marco V, Varghese R, Kapoor-John R, Ardehali R, Owens DK, Hlatky MA. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med. 2007;147:703-716.
3. The SoS Investigators Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery Trial): a randomised controlled trial. Lancet. 2002;360:965-969.
4. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier JRM, Schonberger JP, Buller N, Bonser R, van den Brand MJB, van Herwerden LA, Morel MAM, van Hout BA; Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117-1124.
5. Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J, Vogel D, Grinfeld R, Delacasa A, Garrido M, Oliveri R, Mele E, Palacious I, O'Neill W; for the ERACI II Investigators: Argentine randomised study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and 1-year follow-up results. J Am Coll Cardiol. 2001;37:51-58.
6. Hueb W, Soares PR, Gersh BJ, César LAM, Luz PL, Puig LB, Martinez EM, Oliveira SA, Ramires JAF. The Medicine, Angioplasty, or Surgery Study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol. 2004;43:1743-1751.
7. Mercado N, Wijns W, Serruys P, Sigwart U, Flather M, Stables RH, O'Neill WW, Rodriguez A, Lemos PA, Hueb WA, Geresh BJ, Booth J, Boersma E. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg. 2005; 130:512-519.
8. Serruys PW, Ong AT, van Herwerden LA, Sousa E, Jatene A, Bonnier JJ, Schönberger, Buller N, Bonser R, Disco C, Backyx B, Hugenholtz PG, Firth BG, Unger F. Five year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Studies (ARTS) randomized trial. J Am Coll Cardiol. 2005;46:575-581.
9. Rodriguez A, Baldi J, Pereira CF, Navia J, Alemparte MR, Delacasa A, Vigo F, Vogel D, O'Neill W; on behalf of the ERACI II Investigators. Five year follow-up of Argentine Randomised Trial of Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in Patients with Multiple Vessel Disease (ERACI II). J Am Coll Cardiol. 2005;46: 582-588.
10. Hueb W, Lopes NH, Gersh BJ, Soares P, Machado LA, Jatene FB, Oliveira SA, Ramires JA. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115:1082-1089.
11. Stables RH; on behalf of the SoS Trial Steering Committee and Investigators. Design of the "Stent or Surgery" Trial (SoS): a randomised controlled trial to compare coronary artery bypass grafting with percutaneous transluminal coronary angioplasty and primary stent implantation in patients with multi-vessel coronary artery disease. Semin Interv Cardiol. 1999;4:201-207.
12. Währborg P, Booth JE, Clayton T, Nugara F, Pepper J, Weintraub W, Sigwart U, Stables RH; on behalf of the SoS Neuropsychology Substudy Investigators. Neuropsychological outcome after percutaneous coronary intervention or coronary artery bypass grafting: results from the Stent Or Surgery (SOS) trial. Circulation. 2004;110:3411-3417.
13. Weintraub WS, Mahoney EM, Zhang Z, Chu H, Hutton J, Buxton M, Booth J, Nugara F, Stables RH, Dooley P, Collinson J, Stuteville M, Delahunty N, Wright A, Flather MD, De Cock E. One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the Stent or Surgery trial. Heart. 2004;90:782-788.
14. Hoye A, van Domburg RT, Sonnenschein K, Serruys PW. Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002. Eur Heart J. 2005;26:2630-2636.
15. Aziz S, Stables RH, Grayson AD, Perry RA, Ramsdale DR. Percutaneous coronary intervention for chronic total occlusions: improved survival for patients with successful revascularization compared to a failed procedure. Catheter Cardiovasc Interv. 2007;70:15-20.
16. van den Brand MJ, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, Suryapranata H, Haalebos MM, Wijns W, Wellens F, Balcon R, Magee P, Ribeiro E, Buffolo E, Unger F, Serruys PW. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol. 2002;39:559-564.
17. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R; RAVEL Study Group. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. N Engl J Med. 2002;346:1773-1780.
18. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME; TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003;108:788-794.
19. Tsuchida K, Colombo A, Lefèvre T, Oldroyd KG, Guetta V, Guagliumi G, von Scheidt W, Ruzyllo W, Hamm CW, Bressers M, Stoll HP, Wittebols K, Donohoe DJ, Serruys PW. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II). Eur Heart J. 2007;28: 433-442.
20. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356:1030-1039.
21. Mauri L, Hsieh W, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020-1029.
22. Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;356:1009-1019.
23. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998-1008.
24. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys P. A Pooled analysis of data comparing sirolimus-eluting stents with bare metal stents. N Engl J Med. 2007;356:989-997.
25. BARI Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335: 217-225.
26. Influence of diabetes on 5-year mortality and morbidity in a randomised trial comparing CABG and PTCA in patients with multi-vessel disease: the Bypass Angioplasty Investigation (BARI). Circulation. 1997;96:1761-1769.
27. BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol. 2007;49:1600-1606.
28. Malik IS, Bagger JP, Anderson JR, Kooner JS, Thomas M, Punjabi P, Mayet J, Millane T, Goedicke J, Jamrozik K, de Belder MA, Hall RJ, Beatt KJ. The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design. Am Heart J. 2005;149: 13-19.
29. Comparison of two treatments for multivessel coronary artery disease in individuals with diabetes. Unique identifier: NCT00086450. Available at: http://www.clinicaltrials.gov. Accessed April 1, 2008.
30. Coronary artery revascularization in diabetes (VA CARDS). Unique identifier: NCT00326196. Available at: http://www.clinicaltrials.gov. Accessed April 1, 2008.